JP2012518648A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518648A5
JP2012518648A5 JP2011551272A JP2011551272A JP2012518648A5 JP 2012518648 A5 JP2012518648 A5 JP 2012518648A5 JP 2011551272 A JP2011551272 A JP 2011551272A JP 2011551272 A JP2011551272 A JP 2011551272A JP 2012518648 A5 JP2012518648 A5 JP 2012518648A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
virus
composition according
substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551272A
Other languages
English (en)
Japanese (ja)
Other versions
JP5951996B2 (ja
JP2012518648A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/024914 external-priority patent/WO2010099064A1/en
Publication of JP2012518648A publication Critical patent/JP2012518648A/ja
Publication of JP2012518648A5 publication Critical patent/JP2012518648A5/ja
Application granted granted Critical
Publication of JP5951996B2 publication Critical patent/JP5951996B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551272A 2009-02-24 2010-02-22 イミノ糖及びアレナウイルス感染症を治療する方法 Expired - Fee Related JP5951996B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20239109P 2009-02-24 2009-02-24
US61/202,391 2009-02-24
US27225109P 2009-09-04 2009-09-04
US61/272,251 2009-09-04
PCT/US2010/024914 WO2010099064A1 (en) 2009-02-24 2010-02-22 Iminosugars and methods of treating arenaviral infections

Publications (3)

Publication Number Publication Date
JP2012518648A JP2012518648A (ja) 2012-08-16
JP2012518648A5 true JP2012518648A5 (enExample) 2013-03-21
JP5951996B2 JP5951996B2 (ja) 2016-07-13

Family

ID=42665853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551272A Expired - Fee Related JP5951996B2 (ja) 2009-02-24 2010-02-22 イミノ糖及びアレナウイルス感染症を治療する方法

Country Status (8)

Country Link
US (1) US20100222384A1 (enExample)
EP (1) EP2400843B1 (enExample)
JP (1) JP5951996B2 (enExample)
KR (2) KR101787434B1 (enExample)
CN (1) CN102625660B (enExample)
CA (1) CA2753194A1 (enExample)
ES (1) ES2562635T3 (enExample)
WO (1) WO2010099064A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5600329B2 (ja) 2009-02-23 2014-10-01 ユナイテッド セラピューティクス コーポレーション イミノ糖およびウイルス性疾患を治療する方法
CN104703597A (zh) 2012-06-06 2015-06-10 尤尼特尔滤过性微生物学有限责任公司 新型亚氨基糖及它们的应用
CN102775384B (zh) * 2012-07-27 2015-05-27 中国科学院化学研究所 小钩树碱i和j类似物及其制备方法与应用
HK1221871A1 (zh) * 2013-05-02 2017-06-16 The Chancellor, Masters And Scholars Of The University Of Oxford 使用亚氨基糖进行的糖脂抑制
MX2016003323A (es) 2013-09-16 2016-08-12 Emergent Virology Llc Derivados de dosoxinojirimicina y sus metodos de uso.
IT202000008917A1 (it) * 2020-04-24 2021-10-24 Biovalley Invest Partner S R L Composizioni antivirali

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2834122A1 (de) * 1978-08-03 1980-02-14 Bayer Ag Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
DE2839309A1 (de) * 1978-09-09 1980-03-27 Bayer Ag 3,4,5-trihydroxypiperidin-derivate
DE2853573A1 (de) * 1978-12-12 1980-07-03 Bayer Ag Herstellung von n-substituierten derivaten des l-desoxynojirimycins
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5103008A (en) * 1989-08-17 1992-04-07 Monsanto Company Compound, N-butyl-deoxynojirimycin-6-phosphate
US4994572A (en) * 1989-10-12 1991-02-19 Monsanto Company Synthesis of nojirimycin derivatives
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
WO1995022975A1 (en) * 1994-02-25 1995-08-31 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
WO1999029321A1 (en) * 1997-12-11 1999-06-17 The Chancellor, Masters And Scholars Of The University Of Oxford Inhibition of membrane-associated viral replication
US6689759B1 (en) * 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6610703B1 (en) * 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
GB9828474D0 (en) * 1998-12-24 1999-02-17 British Aerospace Surface topology inspection
ATE402701T1 (de) * 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
JP2003505430A (ja) * 1999-07-26 2003-02-12 ジー・ディー・サール・アンド・カンパニー デオキシノジリマイシンの長鎖n−アルキル誘導体およびグルコセレブロシダーゼ酵素の糖脂質異常蓄積疾患の治療用の薬剤の製造のための使用
US7256005B2 (en) * 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
US6565487B1 (en) * 2000-07-17 2003-05-20 Hai Pin Kuo Exerciser having a forward and rearward adjusting seat
PT2857036T (pt) * 2003-01-31 2017-03-13 Mount Sinai School Of Medicine Of N Y Univ Terapia combinada para o tratamento de distúrbios de deficiência proteica
US7446098B2 (en) * 2003-02-18 2008-11-04 Mount Sinai School Of Medicine Of New York University Combination therapy for treating protein deficiencies
US20060211752A1 (en) * 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US20050256168A1 (en) * 2004-04-28 2005-11-17 Block Timothy M Compositions for oral administration for the treatment of interferon-responsive disorders
US7524829B2 (en) * 2004-11-01 2009-04-28 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
GB0501352D0 (en) * 2005-01-21 2005-03-02 Slingsby Jason H Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
KR20080056688A (ko) * 2005-03-16 2008-06-23 유니버시티 오브 옥스퍼드 Hiv-i용 만노스 면역원
CN101355971A (zh) * 2005-05-17 2009-01-28 阿米库斯治疗学公司 使用1-去氧野尻霉素衍生物治疗庞皮病的方法
AU2006247065B8 (en) * 2005-05-17 2012-07-12 Amicus Therapeutics, Inc. A method for the treatment of Pompe disease using 1-deoxynojirimycin derivatives
CA2616537A1 (en) * 2005-07-27 2007-02-01 University Of Florida Research Foundation, Inc. Small compounds that correct protein misfolding and uses thereof
AU2006272586A1 (en) * 2005-07-27 2007-02-01 University Of Florida Research Foundation, Inc. Use of heat shock to treat ocular disease
US20070244184A1 (en) * 2006-01-09 2007-10-18 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
AU2007241622A1 (en) * 2006-04-24 2007-11-01 Academisch Medisch Centrum Improved treatment of cystic fibrosis
US8975280B2 (en) * 2006-05-24 2015-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Deoxynojirimycin and D-arabinitol analogs and methods of using
US20080138351A1 (en) * 2006-08-02 2008-06-12 United Therapeutics Corporation Liposome treatment of viral infections
JP2010510171A (ja) * 2006-08-21 2010-04-02 ユナイテッド セラピューティクス コーポレーション ウイルス感染症の治療のための併用療法
US20090252785A1 (en) * 2008-03-26 2009-10-08 University Of Oxford Endoplasmic reticulum targeting liposomes
US9040488B2 (en) * 2008-09-02 2015-05-26 Baruch S. Blumberg Institute Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity

Similar Documents

Publication Publication Date Title
JP2010526025A5 (enExample)
JP2010095546A5 (enExample)
JP2012092103A5 (enExample)
JP2006522035A5 (enExample)
JP2012510502A5 (enExample)
JP2010501534A5 (enExample)
JP2010504908A5 (enExample)
JP2009504763A5 (enExample)
JP2010522710A5 (enExample)
JP2014515008A5 (enExample)
JP2010519270A5 (enExample)
JP2009535462A5 (enExample)
JP2008501000A5 (enExample)
JP2013537203A5 (enExample)
JP2011504903A5 (enExample)
JP2011512324A5 (enExample)
JP2007246474A5 (enExample)
JP2018135343A5 (enExample)
JP2015508092A5 (enExample)
JP2009543795A5 (enExample)
JP2008500999A5 (enExample)
JP2013503881A5 (enExample)
JP2012121883A5 (ja) オキサジアゾール誘導体
JP2017197539A5 (enExample)
JP2012518649A5 (enExample)